- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC in the Press, November 18, 2016
A review of our peer-reviewed research in the healthcare and mainstream press.
MIT News cited an August study from The American Journal of Managed Care (AJMC) in an article about data-driven diabetes management. The AJMC study, “Association Among Change in Medical Costs, Level of Comorbidity, and Change in Adherence Behavior,” examined the costs of medication nonadherence for patients with diabetes and other conditions. A formerly nonadherent patient becoming adherent is associated with significant savings, which is why the MIT article is enthusiastic about a smart insulin-pen cap that sends usage data to an app.
An article about pain relievers in The Washington Post mentioned a 2013 AJMC study, “Quantifying the Impact of NSAID-Associated Adverse Events.” The Post article cited the study’s finding that half of seniors 65 years or older take at least 7 doses of nonsteroidal anti-inflammatory drugs (NSAIDs) per week.
Bridging the Vaccination Gap: Insights on Global Immunization Challenges
July 30th 2024On this episode of Managed Care Cast, we speak with Jeffery A. Goad, PharmD, MPH, 2024-2025 president of the National Foundation for Infectious Diseases, on the recent report from the World Health Organization and UNICEF on public immunization rates, with national and global health implications.
Listen
Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO
July 11th 2024On this episode of Managed Care Cast, we're talking with the chief medical officer of CVS Health about recent pharmaceutical innovations, patient-provider relationships, and strategies to reduce drug costs.
Listen
Team-Based CINEMA Program Targets SDOH and Precision Care in Diabetes
December 20th 2024Ian Neeland, MD, discusses the CINEMA program's impact on addressing social determinants of health (SDOH) in Ohio and the importance of precision risk tests to reduce cardiovascular metabolic disease risk.
Read More
